James McKiernan
Neurology · Louisville, KYNPI 1336126515
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 33.0% of the total. Reporting peaked in 2019 at $2,183 and has fallen 99.5% since, to $11 in 2021.
Across 179 payments — averaging $13.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$819
- UCB, Inc.$396
- Amgen$222
- AbbVie$154
- Novartis$144
- Akcea Therapeutics, Inc.$121
- plus $624 from 16 others
What the payments were for
- Speaking & faculty fees$582%
- Food & beverage$2,40997%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 60 | $819 |
| UCB, Inc. | 25 | $396 |
| Amgen | 16 | $222 |
| AbbVie | 21 | $154 |
| Novartis | 13 | $144 |
| Akcea Therapeutics, Inc. | 4 | $121 |
| Eisai Inc. | 5 | $86 |
| AstraZeneca | 4 | $73 |
| Acorda Therapeutics, Inc | 4 | $58 |
| Promius Pharma LLC | 4 | $58 |
| Aprecia Pharmaceuticals, LLC | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $42 |
| Grifols USA, LLC | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 3 | $36 |
| Upsher-smith Laboratories LLC | 2 | $34 |
| Boston Scientific | 2 | $32 |
| Acadia Pharmaceuticals Inc | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$2,479 in reported general payments places this provider in the 55th percentile of 210 neurology providers in Kentucky.
Other neurology in Louisville
- Brian PlatoLouisville$232K
- Kristi NordLouisville$217K
- Angela HardwickLouisville$187K
- Peter HederaLouisville$185K
- Jeffrey FrankLouisville$181K
- Mohammad AlsorogiLouisville$111K
- Tad SeifertLouisville$99K
- Michael SweeneyLouisville$71K
- Michael SowellLouisville$60K
- David RobertsonLouisville$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.